There is a saying that the morning hour has gold in its mouth . It says that getting up early is worthwhile because it is easy to work in the morning and early risers can achieve more. It is the verbatim translation of the Latin textbook sentence aurora habet aurum in ore . This refers to the personified dawn (Latin: aurora ) that wears gold in the mouth and in the hair.
In earlier times, the Latin proverb aurora musis amica (the morning hour is the friend of the muses), which means as much as study in the morning, was first documented in a letter from Erasmus of Rotterdam to his student Christian Northoff one best
Vioxx is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). Vioxx is also related to the nonselective NSAIDs , such as ibuprofen and naproxen. Vioxx is a prescription medicine used to relieve signs and symptoms of arthritis, acute pain in adults, and painful menstrual cycles.30 Sept 2004
How many deaths did Vioxx cause?By the time Vioxx is withdrawn from market, an estimated 20 million Americans have taken the drug. Research later published in the medical journal Lancet estimates that 88,000 Americans had heart attacks from taking Vioxx, and 38,000 of them died.10 Nov 2007
Merck Manipulated the Science about the Drug Vioxx
Published Oct 12, 2017
Scientists from the pharmaceutical giant Merck skewed the results of clinical trials in favor of the arthritis drug, Vioxx, to hide evidence that the drug increased patients’ risk of heart attack. FEATURE
Five tactics business interests use to sideline science, deceive the public and buy influence at the expense of public health and safety.
To increase the likelihood of FDA approval for its anti-inflammatory and arthritis drug Vioxx, the pharmaceutical giant Merck used flawed methodologies biased toward predetermined results to exaggerate the drug’s positive effects. Internal documents made public in litigation revealed that a Merck marketing team had developed a strategy called ADVANTAGE (Assessment of Differences between Vioxx And Naproxen To Ascertain Gastrointestinal tolerability and Effectiveness) to skew the results of clinical trials in the drug’s favor. As part of the strategy, scientists manipulated the trial design by comparing the drug to naproxen, a pain reliever sold under brand names such as Aleve, rather than to a placebo.
The scientists highlighted the results that naproxen decreased the risk of heart attack by 80 percent, and downplayed results showing that Vioxx increased the risk of heart attack by 400 percent. This misleading presentation of the evidence made it look like naproxen was protecting patients from heart attacks, and that Vioxx only looked risky by comparison. In fact, Vioxx has since been found to significantly increase cardiovascular risk, leading Merck to withdraw the product from the market in 2004.
Merck’s manipulation of the science around Vioxx also included a pattern of ghostwriting of scientific articles. Internal documents reveal that in 16 of 20 papers reporting on clinical trials of Vioxx, a Merck employee was initially listed as the lead author of the first draft; on the published versions, an outside academic was listed as the primary author. In one draft of a Vioxx research study that did not yet have a prominent outside name attached, Merck officials listed the lead author only as “External author?” A Merck scientist was also found to have removed the evidence of three heart attacks among patients in a dataset from the results presented.
Tragically, Merck’s manipulation of its data—and the FDA’s resulting approval of Vioxx in 1999—led to thousands of avoidable premature deaths and 100,000 heart attacks. Dr. David Graham, the Associate Director for Science and Medicine in FDA’s Office of Drug Safety, testified in 2004 before the Senate Finance Committee that the FDA’s failure to recall Vioxx earlier had resulted in as many as 55,000 premature deaths from heart attacks and stroke, calling it the equivalent of allowing “two to four jumbo jetliners” to crash every week for five years. Even years after discontinuing use of the drug, patients who have taken Vioxx continue to experience complications.
Our running list of attacks on science—disappearing data, silenced scientists, and other assaults on scientific integrity and science-based policy—provides a representative sample of threats to the federal scientific enterprise.PODCAST
Dr. Topol is director of the Scripps Translational Science Institute, chief academic officer of Scripps Health, professor of genomics at the Scripps Research Institute, and co-founder of the West Wireless Health Institute in La Jolla, Calif. A practicing cardiologist, he has led the flagship, National Institutes of Health-supported Scripps Translational Science Institute since 2006, where he works on innovative genomic and wireless digital technologies aimed at reshaping the future of medicine. Prior to his work at Scripps, Dr. Topol’s efforts are widely credited with leading the Cleveland Clinic to become the foremost center for heart care. While at the Cleveland Clinic, he started a new medical school, led many worldwide clinical trials to advance care for heart disease, and spearheaded the discovery of several genes that increase susceptibility for heart attacks. Dr. Topol pioneered the development of many medications that are routinely used in medical practice, including tissue plasminogen activator, Plavix, Angiomax, and ReoPro. He was the first physician to raise safety concerns about Vioxx. He has published 1100 peer-reviewed articles and more than 30 medical textbooks. He recently became editor-in-chief of the website Medscape. The University of Michigan, where he served on the faculty, established the Eric Topol Professor of Cardiovascular Medicine to recognize his contributions. The University of Rochester, where he attended medical school, awarded him its highest honor, the Hutchinson Medal. In 2012, a poll by Modern Healthcare singled him out as the most influential physician executive in the United States. He was elected to the Institute of Medicine and is one of the top 10 most-cited healthcare researchers. His book, The Creative Destruction of Medicine, was published in 2012.
“A vaccine that is not sterilizing permits the virus to infect you and replicate and as a result you can infect others. Technically it is not a vaccine at all (which by definition prevents infection); it is a prophylactic therapy.”
yEmily Mertz Global News Posted August 10, 2021 6:18 pm Updated August 11, 2021 11:31 am
Global National: Aug 10close video
WATCH (Aug. 5): Dr. Deena Hinshaw, Alberta’s chief medical officer of health, is defending the divisive decision to end the province’s pandemic response plan, despite surging COVID-19 cases. Leave A Comment
The number of active COVID-19 cases in Alberta continued to climb on Tuesday, sitting at 3,463 across the province. Alberta’s active case rate has been rising for the past couple weeks. On July 14, it was 569, by July 26, it had surpassed 1,000, and Aug. 3, it climbed over 2,100 cases. COVID-19 hospitalizations and ICU admissions have also been going up. On Tuesday, there were 133 Albertans in hospital with COVID-19, 29 of whom were being treated in intensive care. That compares to 90 in hospital last Tuesday (23 in ICU) and 82 in hospital (21 in ICU) on Tuesday, July 27. READ MORE: COVID-19: Alberta advocates take fight for health measures in schools to federal government Alberta lifted essentially all public health measures on July 1. STORY CONTINUES BELOW ADVERTISEMENT
Alberta Health confirmed 279 new COVID-19 cases on Tuesday out of about 5,400 tests. Alberta’s positivity rate sat at around 5.3 per cent. Two additional deaths from COVID-19 were reported to Alberta Health in the last 24 hours. READ MORE: Pediatricians plead for strong COVID-19 measures: ‘Abdication of our responsibility’ Premier Jason Kenney said Monday he remains confident in Alberta’s decision to lift COVID-19 safety measures, despite growing concerns from physicians. The Alberta Medical Association section of pediatrics penned a letter to Kenney expressing grave concern over Alberta’s decision to eliminate COVID-19 testing and tracing, and its plan to end mandated isolation for positive cases on Aug. 16. The group says there is no scientific evidence to support the decision as Alberta battles rising cases, particularly of the highly contagious Delta variant, first identified in India. 4:56‘Potentially we could have a perfect storm’: Dr. Noel Gibney on the Delta variant and back-to-school ‘Potentially we could have a perfect storm’: Dr. Noel Gibney on the Delta variant and back-to-school When asked about the letter, Kenney said his government stands by the advice from Alberta’s chief medical officer of health, Dr. Deena Hinshaw. STORY CONTINUES BELOW ADVERTISEMENT
“It’s hardly a revelation that there is a diversity of views in how best to address the COVID challenge,” Kenney said during an announcement about Alberta’s economy in Edmonton. “We’ve accepted without modification the proposal of the chief medical officer for health, based on the extensive research of our public health officials on the new reality of COVID here in Alberta, and around the world, with the widespread protective effect of vaccines.” 0:56Alberta’s COVID-19 reopening plan was developed by chief medical officer and team: Kenney Alberta’s COVID-19 reopening plan was developed by chief medical officer and team: Kenney – Aug 3, 2021 Close contacts of individuals who test positive for COVID-19 are no longer required to isolate, nor are they notified by contact tracers. Come Aug. 16, infected Albertans will also not be required to quarantine. READ MORE: Hinshaw apologizes for causing ‘fear or anger’ over Alberta’s plan to lift COVID-19 measures Alberta currently has the highest active case count in Canada, followed by British Columbia. STORY CONTINUES BELOW ADVERTISEMENT
As of Tuesday, 76.5 per cent of Albertans 12 and older had received one dose of vaccine, while 67.1 per cent were fully immunized. — with files from Canadian Press
Josef Alexander Spickermann (born March 6, 1870 in Bloto, Lodz [1] (probably Zgniłe Błoto ), died March 22, 1947 in Leipzig ) was a German politician and deputy of the German minority in Poland in the Sejm of the Second Polish Republic .
Table of Contents [Verbergen] 1 life 1.1 Family and work 1.2 Political career 2 literature 3 individual proofs Life Edit ] Family and occupation [ edit | Edit ] Spickermann graduated from the school in Łódź and already passed the master craftsman carpentry exam at the age of 19. He was also a real estate dealer in Łódź. At the time of the German occupation from 1939 to 1945 he was senior master of the carpentry guild Litzmannstadt, Reichsgau Wartheland . [1]
Spickermann was married and had nine children, three of whom died in infancy. Three sons and three daughters reached adulthood and they started all families. In 1945, the Spickermanns, who joined other relatives, escaped to Pouch at Bitterfeld . [4]
Political career [ edit | Edit ] From January 1919 Spickermann was a city councilor in Lodz. In the same year Spickermann and Ludwig Wolff were elected as representatives of the German People’s Party (DVP) for the district Lodz- Land Lask – Brzeziny in the Polish Constituent National Assembly (1919-1922) . Spickermann initially remained until 1920 deputies, but was re-elected for 1922-1928 in the Sejm, now for the constituency Konin – Koło – Lentschütz . From 1928 to 1930 he was senator for the Łódź Voivodeship . On 22 November 1930 Spickermann again ran successfully for the Senate, but had to resign his mandate due to an “internal agreement” in the German People’s Association to August Utta . He then retired from politics. [1]
Literature [ edit | Edit ] Bertold Bergmann: Josef Spickermann, life picture of a German parliamentarian , in: Landsmannschaft Weichsel-Warthe: Jahrbuch Weichsel-Warthe 1960 , Munich 1960 [for this article so far not evaluated]. Ursula Brehmer: Responsibility as a task and life law, Josef Alexander Spickermann on the 50th anniversary of death in: Landsmannschaft Weichsel-Warthe: Jahrbuch Weichsel-Warthe 1997 , Berlin / Bonn 1997, pp. 68-72. Karl-Heinz Reschke: Josef Alexander Spickermann, On the 60th anniversary of the death of the Sejmabgeordneter and Senator in Poland , in: Landsmannschaft Weichsel-Warthe: Jahrbuch Weichsel-Warthe 2007 , Wilfried Gerke: Contributions to the History of the Germans in Poland during the Second World War 1939-1945. Herne 2008, p. 67. Hochspringen ↑ Eduard Kneifel: The Protestant-Augsburgischen communities in Poland 1555-1939. Vierkirchen 1971, p. 318. Ursula Brehmer: Responsibility as a task and law of life. Josef Alexander Spickermann on the 50th anniversary of his death. In: Landsmannschaft Weichsel-Warthe: Jahrbuch Weichsel-Warthe 1997 , Berlin / Bonn 1997, p. 68. Hochspringen ↑ Ursula Brehmer: Responsibility as a task and law of life. Josef Alexander Spickermann on the 50th anniversary of his death. In: Landsmannschaft Weichsel-Warthe: Jahrbuch Weichsel-Warthe 1997 , Berlin / Bonn 1997, p. 71. Mads Ole Balling : From Reval to Bucharest – Statistical-Biographical Handbook of the Parliamentarians of German Minorities in Central and Southeastern Europe 1919-1945, Volume 1, 2nd Edition . .
Auntie, Sister. Grandmother, Great-Grandmother, Mother and Wife of German Descent I’ve lived in Australia since 1959 together with my husband Peter. We have four children, eight grandchildren and two great-grandchildren. I started blogging because I wanted to publish some of my childhood memories. I am blogging now also some of my other memories. I like to publish some photos too as well as a little bit of a diary from the present time. Occasionally I publish a story with a bit of fiction in it. Peter, my husband, is publishing some of his stories under berlioz1935.wordpress.com View all posts by auntyutaPublishedNovember 24, 2017
6 thoughts on “My Grandfather was in the Sejm and later in the Senate”catterelEditWell done, Uta – you have made a good start on tracing your ancestors. Be prepared to discover unpleasant facts as well as interesting and sometimes amusing things. Your grandfather was an important man.Reply
auntyutaEditThanks, Cat. Yes, all his children and grandchildren who lived close to where he lived always thought that he was an important man. Grandfather loved to discuss things with the whole family being assembled around the dinner table. A few years after grandfather’s death I met the extended family a few times in Western Germany where they had settled as refugees from Poland. All the family still talked a lot about grandfather. It says in the above article:‘On 22 November 1930 Spickermann again ran successfully for the Senate, but had to resign his mandate due to an “internal agreement” in the German People’s Association to August Utta . He then retired from politics.”Elisabeth, Grandfather’s youngest daughter, talked for instance about this “internal agreement”. I remember her mentioning the name “Utta” in connection with grandfather’s resignation. She did not like it at all that he had to resign!My cousins always liked to research a lot about family history. Two of my cousins are mentioned in the above article. Thanks to them I could find the above article in google.Reply
catterelEditAnd have you googled August Utta? Interesting man, too.
auntyutaEditThanks, Cat. As you suggested, I googled August Utta,https://de.wikipedia.org/wiki/August_UttaI found it interesting that he died already in 1940 aged only 54. Apparently he went to farming for the last couple of years of his life. So what caused his death? I wonder.Grandfather lived to age 77 after having fled with the extended family from Lodz to Pouch (near Bitterfeld) in Germany at the last moment before the Russians occupied Lodz in January/February 1945.https://de.wikipedia.org/wiki/PouchIt says that at the time of the German occupation from 1939 to 1945 Spickermann was senior master of the carpentry guild Litzmannstadt (Lodz) Reichsgau Wartheland.
This is a blog by Kate Kresse that I reblogged here with this comment:
I am sure, some of my followers have experienced war shortages. I am thinking about older people that remember World War Two and the years after the end of the war. I was ten years old when the war in Germany ended. My grandmother was especially good at using every little bit of food, nothing would be thrown out. It stuck with me. I tend to be very careful in not wasting any food if at all possible. 🙂 Both my husband and I had learned to be very careful with money and to avoid of going into debt. Don’t most people in our effluent Western society, that never experienced shortages, behave in a very different way?
Did your parents grow up during the Great Depression? My parents grew up during that time. It affected how they lived their lives. It made them very careful with their money. It made them wise. They knew the importance of saving for the future, gardening for some of their food, and canning or freezing what they could. They stocked up on things when they were marked way down. They did all of this because of wisdom that only comes from experiencing hardship, poverty, and simple necessities being unavailable. As mom told me many times, “your generation takes sufficiency of products or even affluence for granted. My generation never can.” Of course, she was right. Dad spent his career in logistics. I spent part of mine in logistics, inventory control, and production scheduling. Dad and I often discussed trends and the impact of shipping and factory problems on supplies at the…
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government.[4] As part of the Department of Health, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.[5]
Structure of the TGA and medical regulation in Australia[edit]
In Australia, medical products are regulated by the TGA and, for controlled drugs such as cannabis, the Office of Drug Control (ODC). Together the TGA and ODC form the Health Products Regulation Group within the Department of Health. The Health Products Regulation Group comprises 11 regulatory branches and one legal branch, organised into three divisions. The Regulatory Services and Drug Control branch is the only one to not be part of the TGA.[3]
The TGA also includes seven specialised statutory committees, which the agency can call upon for assistance on technical or scientific issues.[6] Four other committees also exist to give guidance on annual influenza vaccines, industry consultation matters, and the Therapeutic Goods Advertising Code.[7]
In September 2003, the Australian and New Zealand Government signed a treaty to establish a common therapeutic regulatory agency for the two countries. Australia New Zealand Therapeutic Products Agency, as it was to be called, would replace the TGA and Medsafe, the national regulator in New Zealand. In June 2011, eight years after the original treaty, Australian Prime Minister Julia Gillard and New Zealand Prime Minister John Key signed a letter of intent, reaffirming plans to create such an agency.[8]
In November 2014, both Australia and New Zealand agreed to cease plans to create a shared regulator, citing “a comprehensive review of progress and assessment of the costs and benefits to each country”. The joint statement announcing the cessation outlines that both the TGA and Medsafe would continue to cooperate on medicine regulation and that the New Zealand Government would still participate in the, now defunct, Council of Australian Governments Health Council.[9]
Wordmark of the Australian Government’s COVID-19 vaccination program.Pfizer–BioNTech vaccine (2021)
On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional approval only recommends the vaccine for patients over the age of 16, pending ongoing submission of clinical data from the vaccine sponsors (the manufacturers, Pfizer and BioNTech).[10] Additionally, every batch of vaccines have their composition and documentation verified by TGA laboratories before being distributed to medical providers.[11]
The Department of Health planned the administration of COVID-19 vaccinations in five phases, organised by the risk of exposure. Border, quarantine, and front-line health and aged care workers were vaccinated first, followed by over 70 year-olds, other health care workers, and essential emergency service members. Following the provisional approval of COMIRNATY, Prime Minister Scott Morrison said that it was planned for the first group to begin vaccinations by February 2021, six weeks earlier than originally planned.[12]
The first public COVID-19 vaccination in Australia actually took place on 21 February 2021 with the Pfizer–BioNTech vaccine at Castle Hill in Sydney. An 84 year-old aged care resident was the first Australian to receive the vaccine. To show confidence in the national immunisation vaccine rollout, Prime Minister Morrison and Chief Medical Officer Professor Paul Kelly also received vaccinations.[13]
On 23 February 2021, Australia’s second shipment of the Pfizer vaccine arrived at Sydney airport. Health Minister Hunt confirmed the arrival of 166,000 doses, and 120,000 more doses expected to arrive in the following week.[14]
On 9 April 2021, Prime Minister Morrison announced that Australia had secured another 20 million doses of Pfizer vaccine on top of 20 million already on order, meaning 40 million doses should be available to Australians in 2021. This was amid concerns about the AstraZeneca vaccine, in rare cases, causing blood clots; see section Oxford–AstraZeneca vaccine below. The additional doses of Pfizer were expected to arrive in Australia in the last quarter of 2021.[15][16]
On 23 July 2021, the TGA approved the Pfizer COVID-19 vaccine for teenagers between 12 to 15 years old.[17]
On 16 February 2021, the Oxford–AstraZeneca vaccine was approved by the TGA for use in Australia. The administration of this vaccine is scheduled to start in March.[18] Two weeks later, on 28 February, the first shipment of the vaccine, around 300,000 doses, arrived at Sydney for rollout from 8 March.[19] On 5 March 2021, Italy stopped the export of AstraZeneca vaccine to Australia due to their slower rollout of that vaccine in the EU.[20] On 23 March, TGA approved the first batch of locally manufactured AstraZeneca vaccine by CSL-Seqirus in Melbourne, and 832,200 doses were ready for rollout in the following weeks.[21]
On 17 June 2021, Federal Health minister Greg Hunt announced a rise in the age limit for administration of the AstraZeneca vaccine. After new advice from the Australian Technical Advisory Group on Immunisation (ATAGI), the vaccine was no longer recommended for people aged under 60 years. This advice came after new cases of blood clotting, thrombosis with thrombocytopenia syndrome (TTS), in those under 60 after AstraZeneca vaccinations.[16]
On 23 June 2021, the Federal government released vaccine allocation projections and forecast that the Oxford-AstraZeneca vaccine would be in “little need” past October 2021 when all Australians over 60 years were expected to be fully vaccinated.[22]
On 25 June 2021, provisional approval was given by the TGA to the Janssen COVID-19 vaccine, the third vaccine for potential use in Australia. Strict conditions were imposed on Janssen which includes further investigation documents related to the efficacy, long term effects and safety concerns that must be provided regularly to TGA. It is still[when?] not included in the vaccination programme.[23]Johnson & Johnson COVID-19 vaccine developed by Janssen
The Australian Government is establishing a COVID-19 Vaccine Claim Scheme to provide further assurance and confidence to patients and health professionals in the COVID-19 vaccine rollout.
Alberta’s active case rate has been rising for the past couple weeks. On July 14, it was 569, by July 26, it had surpassed 1,000, and Aug. 3, it climbed over 2,100 cases.
4:56‘Potentially we could have a perfect storm’: Dr. Noel Gibney on the Delta variant and back-to-school
0:56Alberta’s COVID-19 reopening plan was developed by chief medical officer and team: Kenney
AuntyUta 
_I_(cropped).jpg){kind=link}
